Bar Plot from Scientific Research

The best percentage change in SPD compared with postoperative baseline MRI and the overall ORRs by assigned treatment. Eleven patients had an on-study gross total resection without residual disease and were considered to have best response of stable disease as long as disease progression had not been documented. Patient 22 in the vorasidenib group had a >50% reduction in tumor size compared with baseline that was not confirmed and was therefore categorized as stable disease. Two patients were not included in the plot (patient 24 in the vorasidenib group and patient 22 in the ivosidenib group) owing to changes in selected target lesions measured at one or more postoperative time points that affected best percentage change assessment. a Complete response, PR or mR.

DOI